Sign Out
Lacosamide (Vimpat) is indicated as: monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 16 years and older; adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients aged 16 years or older.
Vimpat: Adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in patients 16 years and older with idiopathic generalised epilepsy.
Vimpat Injection: Adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in patients with epilepsy aged 16 years and older.
Continue with Google